IMPURITIES AVAILABLE FOR 'Palbociclib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Palbociclib. Palbociclib is an oral targeted therapy used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which are crucial for cell cycle progression, thereby slowing cancer cell growth and division. Palbociclib is typically used in combination with hormone therapies such as letrozole or fulvestrant. It has shown to significantly improve progression-free survival in breast cancer patients. Common side effects include neutropenia, fatigue, nausea, and infections. Regular blood monitoring is essential during treatment to manage potential side effects. Buy high quality Palbociclib from Omsynth Lifesciences.